Introduction
Acute GVHD remains a major contributor of non-relapse mortality (NRM) after allo-HCT. 1 Its pathogenesis involves a complex network of interactions between alloreactive T cells, antigen presenting cells (APCs), pro-inflammatory cytokines, and effector cells, leading to target organ injury in the host. 2 In experimental models of allo-HCT, an HDAC inhibitor (vorinostat) reduced pro-inflammatory cytokines 3 through the induction of IDO in a STAT-3-dependent manner 4, 5 and increased Tregs 6 to attenuate GVHD. On the basis of these experimental observations, we recently performed a clinical trial of HDAC inhibition after allo-HCT that demonstrated significantly decreased acute GVHD without increase in relapse. 7 However, whether HDAC inhibition had similar immunological impact on inflammatory cell and Treg responses in humans is not known. 8 In the present study, we explored the role of HDAC inhibition on inflammation, Tconv, and Tregs in patients from the clinical trial 7 of vorinostat post-allogeneic transplant.
Methods

Study Cohort and Sample Collection
Laboratory studies were conducted in 50 patients who underwent a clinical trial (clinicaltrials.gov #NCT00726375). 7 Oral vorinostat was administered 10 days before the stem cell infusion and continued until day 100. Study patients were compared with patients who were similarly transplanted and given standard-of-care treatment but did not receive vorinostat (control cohort). Samples were collected under informed consents and IRB-approved research protocols. 7 Research was conducted in accordance with the Declaration of Helsinki. No differences in clinical characteristics were observed between study participants and control cohort (Supplementary Table 1 ).
Immunoblotting
For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From Histones and STAT-3 in PBMC were assessed by Western blot, as previously described, 7 using antibodies listed in the Supplement.
Cytokine Analyses
Cytokine production was determined in plasma and PBMC supernatant samples by ELISA and in CD11c + PBMC by intracellular staining, as previously described.
7
Phenotype of T lymphocytes
Routine absolute lymphocyte counts (ALC) were performed in the Clinical Hematology
Laboratory. To enumerate CD4 + , CD8 + and Treg cells, PBMC were stained using fluorochromeconjugated anti-human mAbs detailed in the Supplement. To detect recent thymic emigrants (RTE), PBMC were identified using anti-human CD4, CD25, CD31 and CD45RA.
9
RNA Isolation and RT-PCR
Total cellular RNA was isolated from PBMC, reverse-transcribed, and used for real-time PCR analysis of Foxp3 and IDO using previously described methods and primer pairs. Treg-specific-demethylation region (TSDR) Demethylation Assay CD4 + CD25 + Tregs and CD4 + CD25 − Tconv were sorted from PBMC using the Regulatory T Cell Kit (Miltenyi Bioscience). Genomic DNA was isolated and TSDR analysis was performed, as previously described. 9,10 PCR conditions and specific primers pairs are listed in the Supplementary Methods.
Treg Suppression assay
Tregs and Tconv were isolated, as described above. 
Statistical Analysis
Samples from the study and control cohorts were compared using the Mann-Whitney nonparametric test. Comparison of paired samples from the same patient was made using the Wilcoxin matched-pairs signed rank non-parametric test. These statistical analyses were performed using GraphPad Prism 6.0 (GraphPad Software, Inc. La Jolla, CA). A two-sided pvalue of <0.05 indicated statistical significance.
Results and Discussion
Administration of vorinostat increased H3 and H4 acetylation, confirming HDAC inhibition, 8, 11 and these increases had prolonged effects without significant decline 100 days post-transplant Table 2 ). We did not find a clear correlation with clinical outcomes, which we speculate may have been due to the conditioning regimen (reduced intensity) and small number of patients who developed GVHD in our study. 7 HDAC inhibition also reduced the release of pro-inflammatory cytokines by PBMC ex vivo in response to LPS (Figure1C) and by CD11c + after PMA/ionomycin stimulation of bulk PBMC ( Figure 1D ). Table 3 ) or 100 days post-transplant (data not shown).
Patients with GVHD have reduced frequencies of Tregs. [16] [17] [18] In murine models, Tregs attenuate GVHD, 19 and HDAC inhibition increased Treg numbers and enhanced their suppressive function, but did not directly alter non-Treg, i.e., Tconv responses. 3, 6, 14, 20 HDAC inhibition can also enhance suppression by human Tregs 21 and promote the conversion of human T cells into Tregs in vitro. 22 We therefore explored the impact of HDAC inhibition with vorinostat on both
Tregs and Tconv after clinical allogeneic BMT. HDAC inhibition did not significantly alter total lymphocyte or, CD4 + or CD8 + T cell counts, nor did it alter the proliferative response of Tconv to non-specific stimuli (Supplementary Table 4 Foxp3 is a critical regulator of Treg development and function 23 and is subject to epigenetic regulation through methylation of CpG islands within the Treg-specific demethylation region (TSDR). Figure   7) . Thus, although we cannot rule out the possibility that vorinostat also induced Tregs in the periphery, the data suggest that at least a portion of the increased Tregs observed in study patients were natural Tregs derived from the thymus. We next determined the functionality of these Tregs. Tregs isolated from vorinostat-treated patients suppressed effector T cell proliferation more effectively on a per-cell basis ( Figure 2F ). However, antigen-specific functional studies (e.g., recovery of CMV-or EBV-specific T cells) were not performed.
HDAC inhibition in mice increased acetylation of the non-histone protein STAT-3, 5 which is critical for the induction of IDO in APCs 4 , reduction in inflammation, and the regulation of acute GVHD 4 . Because vorinostat reduced acute GVHD 7 and mitigated inflammatory cytokines, we next analyzed STAT-3 acetylation and IDO induction in these patients. Concordantly, levels of acetylated STAT-3 protein were significantly increased with HDAC inhibition 30 days posttransplant and levels remained high at day 100 ( Figure 2G ). Phosphorylated STAT-3 levels
For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From were unchanged ( Figure 2G ), consistent with a previous study. 26 IDO is an intracellular enzyme that degrades tryptophan, suppresses APC function, and induces T cell anergy. 27 IDO mRNA was also induced with HDAC inhibition on day 30 post-transplant (p<0.0001), 7 and remained high at day 100 ( Figure 2H ).
Our data in murine models of HCT have shown that vorinostat modulates the production of inflammatory cytokines and induces IDO expression by host APCs to modulate GVHD after allo-HCT. [3] [4] [5] Additional murine data by others indicate that HDAC inhibitors promote the generation and function of regulatory T cells. 6 Ex vivo studies using human cells have confirmed the abilities of HDAC inhibitors to modulate both APCs and Tregs. 
